Medications That Cannot Be Prescribed Online
Telehealth has made healthcare more accessible across Australia, and in many situations doctors can prescribe medications safely via online consultations. But there are important limits. Some medicines are restricted, high-risk, or heavily regulated, and in many cases they are unlikely to be prescribed through an online-only consult. This is not about being difficult or “withholding treatment” — it is about patient safety, legal obligations, and preventing harm, misuse, and diversion.
It's also important to be precise with wording. In Australia, whether a medicine can be prescribed via telehealth depends on the clinical situation, the patient's history, the medicine's risk profile, professional standards, PBS/authority requirements, pharmacy dispensing rules, and state or territory legislation. So rather than a single universal list, the practical reality is that there are categories of medications that are commonly not prescribed online (or only prescribed online in narrow, carefully controlled circumstances).
This article explains the main categories of medications that are typically restricted or unlikely to be prescribed via online telehealth, why these restrictions exist, what doctors must consider before prescribing, and what you can do if you need ongoing treatment. This content is general information only and not medical advice.
Pre-launch sign up
Join our pre-launch list to receive launch updates and early access to Dociva — an Australian telehealth platform focused on clinically appropriate online consultations and medical certificates.
Early supporters can unlock founding member launch benefits when available.
Join the waitlistWhy some medications are restricted online
Some medicines carry higher risks than others. Risks can include dependence and addiction, overdose, misuse, dangerous side effects, complex monitoring requirements, and the need for physical examination or diagnostic testing before safe prescribing. Online care can limit physical assessment, vital signs, and immediate testing, so clinicians often need to be more conservative when uncertainty is higher.
Restrictions also exist to protect the integrity of prescribing in Australia. Prescribers must follow professional standards and comply with laws around controlled drugs, and pharmacies must dispense safely. Where the risk of harm or misuse is higher, systems are designed to require stronger safeguards: identity verification, stricter documentation, authority approvals, specialist oversight, in-person review, or continuity with a regular GP.
The biggest category: controlled drugs and medicines of dependence
The most common group of medications that are unlikely to be prescribed through online-only consultations are controlled drugs and medicines of dependence. These medicines may be used legitimately for serious medical needs, but they also carry higher risks of harm, misuse, and diversion. Because of this, clinicians often require an established patient relationship, robust records, monitoring, and sometimes permits or authority approvals.
Schedule 8 medicines and other high-risk controlled medicines
In Australia, “Schedule 8” medicines are controlled drugs that require strict controls on prescribing and dispensing. These include many strong pain medicines and some other controlled substances. Even when clinically indicated, these medicines often require careful risk assessment, monitoring, and sometimes state or territory approvals depending on the patient context and medicine type.
Because telehealth can limit assessment and continuity, many services will not prescribe Schedule 8 medicines through online consults, particularly for new patients, new starts, dose escalations, or requests that appear inconsistent with safe prescribing. If you are already on a stable, monitored regimen under a regular doctor, changes are typically managed through your usual care team rather than an online one-off consult.
Benzodiazepines and sedatives
Benzodiazepines and sedative medicines can be appropriate in some clinical scenarios, but they also have risks including dependence, withdrawal, sedation, falls (especially in older adults), interaction with alcohol or other sedatives, and impaired driving. Because of these risks, many telehealth services will not initiate these medicines online, and may be cautious about repeats, dose changes, or short-notice requests.
If a sedating medicine is clinically needed, clinicians often prefer continuity of care with a regular GP, clear documentation, and monitoring rather than a first-time online consult. If you are struggling with sleep or anxiety, doctors can discuss safer first-line options and a structured treatment plan.
Stimulants and ADHD medicines
Stimulant medications used for ADHD and related conditions are tightly regulated and generally require specialist assessment, specific approvals, and careful monitoring. In many cases, they are not appropriate for prescribing through an online GP consult without specialist involvement and documented diagnosis and treatment plans.
If you believe you may have ADHD, the usual pathway involves assessment and diagnosis through appropriate services, then structured management that may include medication, monitoring, and follow-up. Online services can sometimes assist with referrals, but starting restricted stimulant therapy is typically not a simple telehealth request.
Opioid pain medicines and why telehealth is cautious
Opioid medicines can be clinically appropriate in limited situations, but they carry significant risks including dependence and overdose, especially when combined with other sedating medicines or alcohol. Chronic pain management is complex and usually requires a broader plan that may include physical therapy, non-opioid treatments, mental health support, and careful review of function and risk. Telehealth providers are therefore commonly cautious about opioid initiation, ongoing supply, and escalation in online-only settings.
If you have pain that is severe or ongoing, a safer approach is often comprehensive assessment, appropriate investigations (including imaging when needed), and a structured pain plan with follow-up rather than one-off online prescribing.
Medicines that often require physical examination or urgent testing
Some medications may be clinically appropriate only after a physical examination or specific tests. This isn't about bureaucracy; it's because the medicine could be unsafe or ineffective if the diagnosis is wrong, or if certain medical conditions are present. Where examination is important for diagnosis, telehealth may not be the right first step.
Examples of situations where doctors may avoid online prescribing include suspected serious infections, severe breathing problems, chest pain, severe abdominal pain, neurological symptoms, and other high-risk presentations where urgent in-person assessment is required. Telehealth is not suitable for emergencies.
If you want a clear guide, read When Telehealth Is Not Appropriate.
Medicines that typically need strict monitoring
Some medicines require close monitoring due to potential serious side effects, required lab tests, or ongoing risk management. In these situations, a clinician may require established records, recent results, and a clear follow-up pathway before prescribing. Online-only prescribing may be limited if the clinician cannot confirm monitoring requirements are met.
Depending on the medicine and your situation, monitoring can include blood tests, blood pressure, pregnancy-related checks, or specialist follow-up. A telehealth doctor may still help by issuing pathology referrals where appropriate and setting a review plan, but they may not prescribe until results are available and reviewed.
For pathology basics, read What Is a Pathology Referral? and How Blood Test Referrals Are Issued.
Authority and PBS restrictions
Some medicines have special PBS authority requirements or are restricted to particular indications, patient groups, or prescriber types. In those cases, a doctor must meet documentation and criteria requirements, and sometimes obtain approvals. This can be harder to do safely without comprehensive records and a clear clinical picture, so online providers may be conservative and may direct patients back to their usual GP or specialist who has the full history.
The key point is that “can a doctor prescribe it” is not just a technical capability; it must be appropriate, compliant, and defensible based on the patient's circumstances and clinical evidence.
Cannabis and other tightly regulated therapies
Some therapies, including medicinal cannabis products, operate under specific regulatory frameworks and clinical requirements. Access pathways and prescriber obligations can be complex, and not all providers offer these services. Many general telehealth services will not prescribe these medicines, and patients are often managed through specific clinics or specialist pathways with structured documentation and monitoring.
If you are exploring these therapies, a safe approach is to discuss the clinical rationale, risks, interactions, and evidence with an appropriate clinician and ensure you understand the legal and monitoring requirements.
Why “lost script” and “urgent repeat” requests are often declined
Patients sometimes seek urgent scripts for controlled medicines with explanations like “I lost it”, “my GP is away”, or “I ran out early”. Even if the situation is genuine, this is a high-risk scenario because it is also a common pattern used for misuse and diversion. Clinicians must be careful and may decline, particularly when they cannot verify history, dosage, prior supply, or monitoring.
If you have lost a prescription, the safest pathway is usually to contact your usual prescriber or practice, or discuss it with the pharmacy that dispensed your last supply, because they may have records and can guide appropriate next steps. For some medicines, prescribers may need to assess you in person or review records before issuing a replacement.
Identity checks and why they matter more for restricted medicines
Safe online prescribing depends on accurate identity and accurate medical history. For higher-risk medicines, clinicians often apply stricter identity checks, request previous records, and confirm details such as medication history and allergies. If identity cannot be reliably confirmed or history is incomplete, a clinician may refuse to prescribe, particularly for controlled medicines.
This is also why reputable telehealth providers avoid “one-click scripts” and prefer a genuine assessment. It protects patients, prescribers, and the integrity of Australian healthcare.
What you can expect instead: safer alternatives telehealth can offer
If an online doctor cannot prescribe a requested medicine, the consult should still be useful. Depending on your situation, safe alternatives can include a clinical assessment and advice, symptom treatment with lower-risk options, a plan for monitoring, pathology or radiology referrals where clinically appropriate, or a specialist referral when needed.
For referral pathways, read Can Telehealth Doctors Provide Specialist Referrals? and What Is a Radiology Referral?.
How to increase the chance of a safe, successful telehealth prescribing consult
Telehealth works best when the clinician has enough information to prescribe safely. Practical steps include:
For a full preparation guide, read Preparing for a Telehealth Appointment.
A practical summary: medicines that are commonly not prescribed online
While the exact rules depend on clinical context and jurisdiction, the categories below are commonly not prescribed via online-only telehealth (or only prescribed with strict safeguards and continuity):
The consistent theme is safety and defensibility: clinicians prescribe when it is clinically appropriate, lawful, and supported by adequate assessment and monitoring.
How Dociva approaches online prescribing
Dociva is designed around clinically appropriate telehealth, structured assessment, and safe prescribing standards. Where prescribing is clinically appropriate, clinicians may issue prescriptions using compliant methods and provide clear instructions and follow-up. Where it is not appropriate, patients are guided toward safer pathways such as in-person review, investigations, or specialist referral. If you want updates during pre-launch, use pre-launch sign-up.
Frequently Asked Questions (FAQs)
In practice, restrictions depend on the medicine category, clinical context, professional standards, PBS/authority requirements, pharmacy rules, and state or territory controls, so it's more accurate to think in terms of common restricted categories rather than one universal list.
High-risk medicines may require confirmed history, monitoring, and continuity of care; if the clinician cannot verify details or safely assess the situation remotely, they may decline and recommend your usual GP or in-person review.
Sometimes, especially for stable long-term medicines where it is clinically appropriate and safe to prescribe, but clinicians may still need to confirm history, monitoring, and any changes in symptoms or risk factors.
Contact your regular clinic for urgent advice, speak with your pharmacy about safe options, or seek in-person assessment at an appropriate service; telehealth is not suitable for emergencies or high-risk situations where safe history and monitoring cannot be confirmed.
No, reputable services do not guarantee prescriptions; clinicians prescribe based on clinical judgement, safety, and legal requirements.
Yes, telehealth can still provide assessment, advice, lower-risk treatment options where appropriate, investigation referrals, and specialist referrals, along with a clear plan for follow-up or escalation.